Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

You are viewing the site in preview mode

Skip to main content

Table 1 Clinicopathological characteristics in elderly patients following surgical removal of gastric adenocarcinoma

From: Construction and validation of a novel nomogram based on the log odds of positive lymph nodes to predict cancer-specific survival in elderly patients with gastric adenocarcinoma after radical surgery

Variable

NO. (%)

P value

Training

cohort

Internal validation cohort

External validation cohort

Sex

   

< 0.001

Female

715(37.9)

295(36.4)

58(24.5)

  

Male

1173(62.1)

515(63.6)

179(75.5)

  

Race

   

< 0.001

White

1210(64.1)

506(62.5)

0

  

Black

191(10.1)

96(11.8)

0

  

Other

487(25.8)

208(25.7)

237(100)

  

Age, years

   

< 0.001

≤ 80

1472(78.0)

635(78.4)

231(97.5)

  

>80

416(22.0)

175(21.6)

6(2.5)

  

Marital status

   

< 0.001

Unmarried

704(37.3)

304(37.5)

8(3.4)

  

Married

1184(62.7)

506(62.5)

229(96.6)

  

Site

   

< 0.001

Cardia

503(26.6)

195(24.1)

144(60.8)

  

Non-cardia

1385(73.4)

615(75.9)

93(39.2)

  

Tumor grade

   

< 0.001

Well

717(38.0)

306(37.8)

58(24.5)

  

Poor

1171(62.0)

504(62.2)

179(75.5)

  

Stage

   

< 0.001

I

561(29.7)

230(28.4)

16(6.8)

  

II

539(28.6)

238(29.4)

66(27.8)

  

III

788(41.7)

342(42.2)

155(65.4)

  

T stage

   

< 0.001

T1

491(26.0)

193(23.8)

15(6.3)

  

T2

258(13.7)

141(17.4)

25(10.6)

  

T3

760(40.3)

301(37.2)

33(13.9)

  

T4

379(20.0)

175(21.6)

164(69.2)

  

N stage

   

< 0.001

N0

825(43.7)

337(41.6)

54(22.8)

  

N1

414(21.9)

192(23.7)

55(23.2)

  

N2

305(16.2)

138(17.0)

59(24.9)

  

N3

344(18.2)

143(17.7)

69(29.1)

  

Size, cm

   

< 0.001

< 2.7

570(30.2)

241(29.8)

40(16.9)

  

2.7–5.3

763(40.4)

303(37.4)

113(47.7)

  

> 5.3

555(29.4)

266(32.8)

84(35.4)

  

LODDS

   

< 0.001

LODDS1

933(49.4)

383(47.3)

67(28.3)

  

LODDS2

626(33.2)

274(33.8)

107(45.1)

  

LODDS3

329(17.4)

153(18.9)

63(26.6)

  

Chemotherapy

   

< 0.001

No

1028(54.4)

444(54.8)

93(39.2)

  

Yes

860(45.6)

366(45.2)

144(60.8)

  

Radiotherapy

   

< 0.001

No

1316(69.7)

575(71.0)

235(99.2)

  

Yes

572(30.3)

235(29.0)

2(0.8)